Breaking News Instant updates and real-time market news.

CIR

Circor

$59.45

0.38 (0.64%)

09:05
10/06/16
10/06
09:05
10/06/16
09:05

CIRCOR cuts Q3 adjusted EPS view to 41c-45c, below prior view of 45c-55c

CIRCOR International announced preliminary financial results for the third quarter. The company expects Q3 sales of $133M-$135M, compared with the previous guidance range of $140M-$150M. "Our preliminary third quarter results reflect the prolonged weakness in the Energy markets across both short cycle and long cycle businesses. There was a sharper than anticipated drop in book and ship orders in our Instrumentation and Sampling business in the quarter. In addition, the supplier quality issues we noted in the second quarter in our defense business continued to impact shipments in the third quarter. Despite these adverse market conditions, we continue to focus on our simplification and growth programs. We will provide additional details and fourth-quarter guidance during our regular earnings call later this month," said Scott Buckhout, President and Chief Executive Officer of CIRCOR.

CIR Circor
$59.45

0.38 (0.64%)

05/02/16
STFL
05/02/16
UPGRADE
STFL
Buy
CIRCOR upgraded on higher oil prices, management at Stifel
As noted earlier, Stifel upgraded CIRCOR to Buy from Hold. The firm thinks that the company's distributed valve business will benefit as higher oil prices spur E&P companies to complete their wells more quickly. Additionally, the firm is upbeat on the company's management and believes that it has a strong balance sheet. Target $68.
05/02/16
05/02/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Sarepta (SRPT) upgraded to Outperform at Oppenheimer by analyst Christopher Marai, who said he uncovered several findings supporting eteplirsen's accelerated approval case, including identifying other "highly negative" panel votes that have previously been overruled by the FDA, particularly for unmet need. Marai also thinks the acquisition comps of competitors Santaris and Prosensa place a floor on Sarepta's valuation. 2. Alexion (ALXN) upgraded to Outperform at BMO Capital citing the ideal entry point following the decline in the stock. The firm expects Soliris to be a $1.5B opportunity for the company, and predicts that Alexion will be able to "maintain the vast majority of its PNH and aHUS revenue stream," despite increased competition. 3. CIRCOR (CIR) upgraded to Buy at Stifel because the firm thinks that the company's distributed valve business will benefit as higher oil prices spur E&P companies to complete their wells more quickly. Additionally, the firm is upbeat on the company's management and believes that it has a strong balance sheet. 4. L-3 Communications (LLL) upgraded to Buy at Goldman by analyst Noah Poponak, who said L-3 has underperform the Defense peer group for the last two years and believes bar remains low and and sees room for upward estimate revisions. Poponak continues to believe the US Defense budget is at a trough and expects that to translate to an acceleration in L-3 organic revenue growth and margin improvement ahead. 5. Colgate-Palmolive (CL) upgraded to Neutral at Goldman with analyst Jason English saying the company's earnings visibility has improved and that he no longer sees downside risk to consensus estimates. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/03/16
SIDC
05/03/16
DOWNGRADE
SIDC
Neutral
CIRCOR downgraded to Neutral from Buy at Sidoti
Sidoti downgraded CIRCOR to Neutral citing valuation and maintained its $62 price target.
09/20/16
KEYB
09/20/16
INITIATION
KEYB
Sector Weight
CIRCOR initiated with a Sector Weight at KeyBanc

TODAY'S FREE FLY STORIES

JBHT

J.B. Hunt

$120.64

-0.42 (-0.35%)

14:35
01/17/18
01/17
14:35
01/17/18
14:35
Technical Analysis
Technical Earnings Preview: J.B. Hunt near life highs before earnings »

At time of writing and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XRX

Xerox

$31.91

-0.44 (-1.36%)

14:35
01/17/18
01/17
14:35
01/17/18
14:35
Hot Stocks
Deason reports 6% stake in Xerox, demands disclosure of JV pact with Fujifilm »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:35
01/17/18
01/17
14:35
01/17/18
14:35
General news
Treasury Action: yields held near highs »

Treasury Action: yields…

EXAS

Exact Sciences

$52.95

0.33 (0.63%)

, VNRX

VolitionRx

$2.95

0.0441 (1.52%)

14:31
01/17/18
01/17
14:31
01/17/18
14:31
Hot Stocks
Analysts stay bullish on Exact Sciences after ASCO abstract prompts pullback »

Shares of Exact Sciences…

EXAS

Exact Sciences

$52.95

0.33 (0.63%)

VNRX

VolitionRx

$2.95

0.0441 (1.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 26

    Feb

  • 29

    Mar

AG

First Majestic

$7.36

0.0106 (0.14%)

14:30
01/17/18
01/17
14:30
01/17/18
14:30
Options
Far upside call buyers in First Magestic as shares trade flat »

Far upside call buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNO

Vornado

$71.16

-0.05 (-0.07%)

14:26
01/17/18
01/17
14:26
01/17/18
14:26
Hot Stocks
Vornado raises dividend to 63c per share »

Vornado Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALX

Alexander's

$379.05

-3.045 (-0.80%)

14:24
01/17/18
01/17
14:24
01/17/18
14:24
Hot Stocks
Alexander's boosts quarterly dividend to $4.50 per share »

Alexander's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$147.07

0.21 (0.14%)

14:22
01/17/18
01/17
14:22
01/17/18
14:22
Hot Stocks
USPTO board says Janssen Oncology patent claims unpatentable »

In a final written…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 16

    Feb

  • 08

    Mar

LOCO

El Pollo Loco

$10.10

-0.2 (-1.94%)

14:20
01/17/18
01/17
14:20
01/17/18
14:20
Options
Bullish option flow in El Pollo Loco »

Bullish option flow in El…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:20
01/17/18
01/17
14:20
01/17/18
14:20
General news
Fed's Beige Book said the economy continued to expand »

Fed's Beige Book…

$NSD

NASDAQ Market Internals

14:17
01/17/18
01/17
14:17
01/17/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
01/17/18
01/17
14:16
01/17/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRSP

Crispr Therapeutics

$27.18

-1.34 (-4.70%)

14:12
01/17/18
01/17
14:12
01/17/18
14:12
Recommendations
Crispr Therapeutics analyst commentary  »

Piper says European…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MS

Morgan Stanley

$54.72

0.12 (0.22%)

14:12
01/17/18
01/17
14:12
01/17/18
14:12
Technical Analysis
Technical Earnings Preview: Morgan Stanley near 52-week high before news »

The stock has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

INTC

Intel

$43.14

-0.1 (-0.23%)

14:10
01/17/18
01/17
14:10
01/17/18
14:10
Options
Large block of puts in Intel as shares advance »

Large block of puts in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 24

    Jan

  • 25

    Jan

WRB

W. R. Berkley

$70.12

0.7 (1.01%)

14:09
01/17/18
01/17
14:09
01/17/18
14:09
Hot Stocks
W. R. Berkley combines professional liability units »

W. R. Berkley announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

ONTX

Onconova

$1.74

-0.0901 (-4.92%)

14:05
01/17/18
01/17
14:05
01/17/18
14:05
Downgrade
Onconova rating change  »

Onconova downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

CY

Cypress Semiconductor

$16.90

-0.17 (-1.00%)

14:05
01/17/18
01/17
14:05
01/17/18
14:05
Options
Cypress Semiconductor call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:05
01/17/18
01/17
14:05
01/17/18
14:05
General news
Apple tax repatriation windfall may total $38 B »

Apple tax repatriation…

14:04
01/17/18
01/17
14:04
01/17/18
14:04
General news
Beige Book says employment, wages grew at modest pace »

The latest Beige Book…

14:03
01/17/18
01/17
14:03
01/17/18
14:03
General news
Fed's Beige Book shows 11 Districts reporting modest to moderate gains »

The Federal Reserve Beige…

TRNC

tronc

$17.97

-0.35 (-1.91%)

14:01
01/17/18
01/17
14:01
01/17/18
14:01
Initiation
tronc initiated  »

tronc initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

ENDP

Endo

$8.01

0.06 (0.75%)

13:55
01/17/18
01/17
13:55
01/17/18
13:55
Options
Endo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:45
01/17/18
01/17
13:45
01/17/18
13:45
General news
NY Fed accepted $20.55 B in daily reverse repos »

NY Fed accepted $20.55 B…

13:45
01/17/18
01/17
13:45
01/17/18
13:45
General news
Breaking General news story  »

December Beige Book to be…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.